Event: BioDuro Symposium - Innovative Approaches to Accelerating Drug Discovery and Development
Registration Link: https://bioduro.com/landing/symposium-sf-2018/
How can we accelerate successful drug discovery and development?
The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.
Join us on Thursday, March 22, 2018 for an afternoon of lunch, insightful presentations and discussion, followed by a networking and happy hour reception.
BioDuro invites you to hear from industry experts on:
From Small Fragments to Big Drugs: Fragment-based Drug Discovery
Dan Erlanson, Ph.D | Co-founder and VP of Chemistry | Carmot Therapeutics
From Fragments to Drugs: Playing Quick Molecular Scrabble with Protein Crystallography
Debanu Das, Ph.D | Co-founder and CEO | Accelero Biostructures
Role of DMPK in Drug Discovery and Development
JP Shaw, Ph.D | Independent Pre-Clinical DMPK Consultant
Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models
Tommy Broudy, Ph.D | CEO | Molecular Response
Non-Toxic Pre-Clinical Formulations for Insoluble Compounds: Applying Enabled Formulations Approaches to Late Phase Discovery
Blair West, Ph.D | Chief Science Officer, Global CMC Solutions | BioDuro
Rapid Development and Scale-up of Solubilized Dosage Forms
Ruchit Trivedi, Ph.D | Associate Director, Formulation | BioDuro
We look forward to seeing you in San Francisco!
12:00 PM- 12:30 PM
12:30 PM- 5:00 PM
Networking Happy Hour
5:00 PM- 6:00 PM
Registration for this event is free, but space is limited. RSVP here!
RSVP – $0 (USD)